Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 

Weak Chinese and European data spooks markets

By midday the FTSE 100 was down 0.7% to 6,826.50 as fragile investor confidence was punctured by soft Chinese and European economic data and a lack of progress on Brexit.

Balfour Beatty raises outlook on profits amid gains from infrastructure sale

Balfour Beatty said Friday full-year performance would be above previous expectations in the wake of an additional infrastructure investments sale in December.

Aggreko wins $200m Olympic supply contract

Aggreko said Friday it had been awarded a $200m supply contract by The Tokyo Organising Committee of the Olympic and Paralympic Games to supply temporary electricity systems.

SThree sees profit beating market expectations; CEO to stand down

Specialist recruitment firm SThree said it expected to post a full-year adjusted profit slightly ahead of the current market consensus range.

ReNeuron posts loss as spending continues on stem-cell treatment candidates

Stem cell-based therapy company ReNeuron Group posted a first-half loss as it continued to develop potential treatments for stroke sufferers and sight problems.

Registered users only

The page you wish to access is only available to Registered Users

Registration is FREE and you will have access to a large range of FREE and Premium Services.

If you are already Registered please use the login form to the right.

Are you a Shares subscriber trying to log on?

If you have any problems email


Register now for free